Drawing for VERSAVITA

USPTO serial 85150796

VERSAVITA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MICHOS, JOHN E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VERSAVITA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R. Meyer

JAMES R. MEYER SCHNADER HARRISON SEGAL & LEWIS LLP1600 MARKET ST STE 3600PHILADELPHIA, PA 19103-7286UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical polymers for use in the manufacture of surgical implantsACTIVE—
005Pharmaceutical preparations, namely, anti-psychotics, anti-cancer preparations, anticholinergics, hormone suppressants and 5-alpha reductase inhibitors; and artificial surgical implant drug delivery system containing anti-psychotics, anti-cancer preparations, anticholinergics, hormone suppressants and 5-alpha reductase inhibitorsACTIVE—
010Surgical implants comprising artificial materials for use in drug deliveryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 3, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 3, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 18, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 16, 2012EX1GSOU EXTENSION 1 GRANTED—
Apr 16, 2012EXT1SOU EXTENSION 1 FILED—
Apr 16, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 1, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 6, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 6, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 24, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Jul 24, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 24, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 24, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 15, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Jul 15, 2011ALIEASSIGNED TO LIE—
Jul 15, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 15, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 15, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 23, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2011DOCKASSIGNED TO EXAMINER—
Oct 26, 2010TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Oct 26, 2010PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 17, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 15, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance